An evaluation of pixantrone for the treatment of non-Hodgkin’s lymphoma
Sign Up to like & getrecommendations! Published in 2018 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2018.1528232
Abstract: ABSTRACT Introduction: The overall prognosis for patients with relapsed or refractory aggressive non-Hodgkin’s lymphomas is poor. Only a minority of patients are able to receive autologous stem cell transplantation. Patients not transplant-eligible or patients relapsing… read more here.
Keywords: lymphoma; treatment; non hodgkin; pixantrone ... See more keywords